U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409389) titled 'Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration' on Jan. 18.
Brief Summary: This prospective, double-blind, randomized controlled trial aims to evaluate the efficacy and safety of repeated low-level red-light (RLRL) therapy in patients with dry age-related macular degeneration (AMD). The primary objective is to assess the effect of RLRL therapy on visual function in patients with dry AMD, while the secondary objective is to evaluate its safety and tolerability.
Seventy-four participants aged 50 years or older with dry AMD will be enrolled and randomly assigned in a 1:1 ratio to either the active RLRL in...